The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
The SDIVF R&D CENTRE is owned by the Hospital for Reproductive Medicine of Shangdong University (SDUIVF), and serves as a research and development unit of The National Reproductive Centre for Assisted Reproductive Technology and Reproductive Genetics (NRC-ARTRG) under the Ministry of Science and Technology of the People’s Republic of China (MOST). The branch in Hong Kong acts as strategic platform for high-technologies development of reproductive medicine, international resource sharing and technology translation. The Research team is formed by talents and technologists from NRC-ARTRG, SDUIVF and Hong Kong’s professional R&D institutes, and is dedicated to provide state-of-the-art technologies and products to boost the quality of reproductive healthcare and to decline probability of birth defect.
Targeting the clinic and social requirements on reproductive healthcare, SDIVF R&D CENTRE aims to perform cutting-edge research on infertility diagnosis and treatment, assisted reproductive technologies and genetic diseases diagnosis. Current deliveries include enhanced cryopreservation of oocyte, intelligent integrated system for assisted reproductive technology, genetic biology screening for hereditary diseases, single cell sequencing, and therapeutic drug screening for infertility. The Centre has also developed screening & diagnosis kits with successful clinical application for more than 100 types of monogenetic diseases covering congenital deafness, hepatolenticular degeneration.